Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: HomeServe plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: FirstGroup plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Euromoney Institutional Investor plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: Countryside Partnerships plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: ContourGlobal plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capricorn Energy plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
Form 8.3 - The Vanguard Group, Inc.: Capital & Counties Properties plc
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences: https://mms.businesswire.com/media/20191104005218/en/753909/5/NSTG-Logo-19-%28002%29.jpg
NanoString to Webcast Presentations from Two Upcoming Healthcare Conferences


NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast

Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results: https://mms.businesswire.com/media/20191107005278/en/707846/5/Aurinia-logo-web-700px.jpg
Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results


Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for the second quarter ended June 30, 2022. Amounts, unless specified otherwise, are

Stevanato Group Reports Second Quarter 2022 Financial Results: https://mms.businesswire.com/media/20220601006234/en/1474001/5/JPG_Logo_SG_RGB.jpg
Stevanato Group Reports Second Quarter 2022 Financial Results


Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology, and life sciences industries, today

Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Brewin Dolphin Holdings plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
Form 8.3 - The Vanguard Group, Inc.: Biffa plc
DGAP-News: Coreo AG Annual General Meeting - approval for all proposed resolutions
DGAP-News: Coreo AG Annual General Meeting - approval for all proposed resolutions
DGAP-News: Coreo AG Annual General Meeting - approval for all proposed resolutions
Director/PDMR Shareholding
Director/PDMR Shareholding
Director/PDMR Shareholding
DGAP-News: Lünendonk Ranking for Mid-size IT Companies: SNP Climbs to Fourth Place
DGAP-News: Lünendonk Ranking for Mid-size IT Companies: SNP Climbs to Fourth Place
DGAP-News: Lünendonk Ranking for Mid-size IT Companies: SNP Climbs to Fourth Place
2022 Annual Report and Notice of Annual General Meeting
2022 Annual Report and Notice of Annual General Meeting
2022 Annual Report and Notice of Annual General Meeting
Reply named a Visionary in the 2022 Gartner® Magic Quadrant™ for Warehouse Management Systems for Third Consecutive Year: https://mms.businesswire.com/media/20200310005095/en/778528/5/bg.jpg
Reply named a Visionary in the 2022 Gartner® Magic Quadrant™ for Warehouse Management Systems for Third Consecutive Year


Reply, thanks to its proprietary WMS solution suites LEA Reply™ and Click Reply™ has been recognized as a Visionary in the annual Gartner Magic Quadrant for Warehouse Management Systems among 17

Ørsted to present results for first half-year 2022 on 11 August
Ørsted to present results for first half-year 2022 on 11 August
Ørsted to present results for first half-year 2022 on 11 August
'Surgutneftegas' PJSC: Information statement on income paid on the issuer’s securities
'Surgutneftegas' PJSC: Information statement on income paid on the issuer’s securities
'Surgutneftegas' PJSC: Information statement on income paid on the issuer’s securities
DGAP-News: Allterco JSCo reports unaudited consolidated H1 2022 results on 15 August 2022 – Invitation to earnings webcast/call on 16 August 2022
DGAP-News: Allterco JSCo reports unaudited consolidated H1 2022 results on 15 August 2022 – Invitation to earnings webcast/call on 16 August 2022
DGAP-News: Allterco JSCo reports unaudited consolidated H1 2022 results on 15 August 2022 – Invitation to earnings webcast/call on 16 August 2022
SES H1 2022 Results: https://mms.businesswire.com/media/20191129005253/en/290384/5/SES_Logo_BL_M.jpg
SES H1 2022 Results


SES S.A. announces financial results for the six months ended 30 June 2022.



Solid First Half financial performance




  • Revenue of €899 million (+2.8% YOY as reported) and Adjusted EBITDA(1) of

DGAP-News: Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the European Defense Fund for Development of Medical Countermeasures
DGAP-News: Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the European Defense Fund for Development of Medical Countermeasures
DGAP-News: Eckert & Ziegler Affiliate to Receive Multi-Million Euro Grant from the European Defense Fund for Development of Medical Countermeasures
DGAP-Adhoc: Scout24 SE increases guidance for the financial year 2022 for revenue growth to 13%-15% and for growth of EBITDA from ordinary activities to 10%-12%
DGAP-Adhoc: Scout24 SE increases guidance for the financial year 2022 for revenue growth to 13%-15% and for growth of EBITDA from ordinary activities to 10%-12%
DGAP-Adhoc: Scout24 SE increases guidance for the financial year 2022 for revenue growth to 13%-15% and for growth of EBITDA from ordinary activities to 10%-12%
EVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
EVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U
EVRAZ plc: UNAUDITED INTERIM FINANCIAL RESULTS FOR H1 2022U